News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Critic at Large
Critic at Large
Opinion: Birds of a Feather?
Geoffrey E. Hill | Mar 10, 2017
Taking into account the interaction of nuclear and mitochondrial genes in birds holds the promise of more objectively defining what constitutes a species.
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Opinion: Ethical Considerations of “Three-Parent” Babies
John D. Loike and Nancy Reame | Dec 22, 2016
Mitochondrial replacement therapy raises important societal and ethical concerns, but should be embraced for its utility in preventing disease.
Opinion: An Ethical Code for Conferences
Wolf B. Frommer | Dec 2, 2016
This fundamental form of scientific communication is threatened by modern recording technology and researchers who refuse to adhere to an age-old ethical code.
Opinion: Not All Genetic Databases Are Equal
Charles M. Strom | Dec 1, 2016
Sorting out which data sets are clinical-grade is key to helping patients.
Opinion: Aging, Just Another Disease
Mutaz Musa | Nov 1, 2016
No longer considered an inevitability, growing older should be and is being treated like a chronic condition.
Opinion: Fixing Science’s Human Bias
Edward Courchaine, Sarah Smaga | Sep 1, 2016
It’s time to accelerate the conversation about why the research community is still not diverse.
Opinion: Our Inner Caveman
João Pedro de Magalhães | Aug 1, 2016
The modern human brain evolved in social and environmental settings very unlike today’s. Despite our cultural and technological progress, tribal instincts remain.
The Global Science Era
Ephraim M. Govere | May 1, 2016
As international collaboration becomes increasingly common, researchers must work to limit their own biases and let cultural diversity enhance their work.
Amy K. LeBlanc, Timothy M. Fan, Nicola Mason | Apr 1, 2016
Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.